Merck Welireg receives European Commission nod for two indications Ruchika Sharma19 Feb 2025 10:30 AM ISTRahway: Merck, known as MSD outside of the United States and Canada, has received conditional approval from the European Commission (EC) for...
Aurobindo Pharma arm CuraTeQ Biologics gets UK MHRA nod for cancer treatment Bevqolva Ruchika Sharma22 Dec 2024 1:30 PM ISTHyderabad: CuraTeQ Biologics s.r.o., a step-down subsidiary of Aurobindo Pharma Limited, has announced that it has obtained marketing...
Aurobindo Pharma arm bags USFDA nod for cancer drug Pazopanib Ruchika Sharma5 Dec 2024 5:09 PM ISTHyderabad: Aurobindo Pharma Limited has announced that its wholly owned subsidiary company, EugiaPharma Specialities Limited, has received final...
Journal Club: Combined transarterial embolization, percutaneous image-guided ablation for T1B, central renal tumors treatment in high surgical risk patients Dr. Nandita Mohan7 Nov 2024 9:30 PM ISTA combination of transarterial embolization and percutaneous CT-guided ablation was an effective, well-tolerated, and safe treatment for patients with...
New imaging technique accurately detects aggressive kidney cancer, claims study Dr. Kamal Kant Kohli22 Oct 2024 5:00 AM ISTA new study led by investigators from the UCLA Health Jonsson Comprehensive Cancer Center has demonstrated a new, non-invasive imaging technique can...
Zydus Lifesciences gets Mexican regulatory authority marketing nod for cancer drug Bhava Ruchika Sharma22 July 2024 2:59 PM ISTAhmedabad: Zydus Lifesciences Limited has announced that the Mexican regulatory authority COFEPRIS (Federal Commission for the Protection Against...
Subcutaneous Nivolumab as Effective as IV injection for Renal Cell Carcinoma-With Much Faster Treatment Time Dr. Kamal Kant Kohli17 Feb 2024 2:30 AM ISTSubcutaneous injection of the immunotherapy nivolumab (brand name Opdivo) is noninferior to intravenous delivery and dramatically reduces treatment...
Merck Welireg gets USFDA approval for kidney cancer Ruchika Sharma15 Dec 2023 12:30 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced that the U.S. Food and Drug Administration (FDA) has approved...
MSD wins DCGI nod for Keytruda for treatment of triple negative breast cancer, renal cell carcinoma Ruchika Sharma26 Oct 2023 11:32 AM ISTKEYTRUDA is an anti-programmed death receptor-1 (PD-1) therapy that works by increasing the ability of the body's immune system to help detect and...
Merck declares topline results from Phase 3 trial of Welirag Ruchika Sharma19 Aug 2023 4:04 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced topline results from LITESPARK-005, the first positive Phase 3...
Evaluation, Management, and Follow Up of Renal Mass and Localized Renal Cancer: AUA Guideline Dr. Kamal Kant Kohli10 April 2023 9:15 AM ISTRenal masses are a biologically heterogeneous group of tumors ranging from benign masses to cancers that can be indolent or aggressive.7,8 The true...
Pre and Postoperative eGFR independent risk factor for CKD after Radical Nephrectomy Dr.Niharika Harsha B8 Dec 2022 7:30 PM ISTA new study found that preoperative estimated glomerular filtration rate (eGFR), age, and immediate postoperative eGFR are independent risk factors...
